Advanced Anti-Wrinkle Therapy Cicatricure
NDC 50066-021, Avobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%, cream, from Genomma Lab.
- Product NDC
- 50066-021
- Status
- Listed
- Labeler
- Genomma Lab
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH NOT FINAL
- Application
- part352
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50066-021 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AVOBENZONE3 g/100g
- OCTINOXATE7.5 g/100g
- OCTISALATE5 g/100g
- OCTOCRYLENE2.7 g/100g
- OXYBENZONE4 g/100g
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50066-021-01 | 50066002101 | 1 TUBE in 1 CARTON (50066-021-01) / 42 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50066-021 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50066-021 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50066-021. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.